Articles with public access mandates - Samuel Z. Goldhaber, MDLearn more
Not available anywhere: 24
Risk of recurrent venous thromboembolism: a Danish nationwide cohort study
IE Albertsen, PB Nielsen, M Søgaard, SZ Goldhaber, TF Overvad, ...
The American Journal of Medicine 131 (9), 1067-1074. e4, 2018
Mandates: US National Institutes of Health
Venous thromboembolism in heart failure: preventable deaths during and after hospitalization
G Piazza, SZ Goldhaber, DM Lessard, RJ Goldberg, C Emery, ...
The American journal of medicine 124 (3), 252-259, 2011
Mandates: US National Institutes of Health, Heart and Stroke Foundation of Canada
Primary prevention of venous thromboembolism with apixaban for multiple myeloma patients receiving immunomodulatory agents
RF Cornell, SZ Goldhaber, BG Engelhardt, J Moslehi, M Jagasia, ...
British journal of haematology 190 (4), 555-561, 2020
Mandates: US National Institutes of Health
Venous thromboembolism in patients with symptomatic atherosclerosis
G Piazza, SZ Goldhaber, DM Lessard, RJ Goldberg, C Emery, ...
Thrombosis and haemostasis 106 (12), 1095-1102, 2011
Mandates: US National Institutes of Health
Dabigatran versus warfarin for acute venous thromboembolism in elderly or impaired renal function patients: pooled analysis of RE-COVER and RE-COVER II
SZ Goldhaber, S Schulman, H Eriksson, M Feuring, M Fraessdorf, ...
Thrombosis and haemostasis 117 (11), 2045-2052, 2017
Mandates: US National Institutes of Health
Upper extremity DVT versus lower extremity DVT: perspectives from the GARFIELD-VTE registry
W Ageno, S Haas, JI Weitz, SZ Goldhaber, AGG Turpie, S Goto, ...
Thrombosis and haemostasis 119 (08), 1365-1372, 2019
Mandates: US National Institutes of Health
Prevalence of thrombocytosis in critically ill patients and its association with symptomatic acute pulmonary embolism
KM Ho, S Chavan
Thrombosis and haemostasis 109 (02), 272-279, 2013
Mandates: US National Institutes of Health, National Health and Medical Research …
Sulodexide versus control and the risk of thrombotic and hemorrhagic events: meta-analysis of randomized trials
B Bikdeli, S Chatterjee, AJ Kirtane, SA Parikh, GM Andreozzi, NR Desai, ...
Seminars in Thrombosis and Hemostasis 46 (08), 908-918, 2020
Mandates: US National Institutes of Health
NOACs for treatment of venous thromboembolism in clinical practice
S Schulman, D Singer, W Ageno, IB Casella, M Desch, SZ Goldhaber
Thrombosis and haemostasis 117 (07), 1317-1325, 2017
Mandates: US National Institutes of Health
Use of prophylaxis for prevention of venous thromboembolism in patients with isolated foot or ankle surgery: a systematic review and meta-analysis
B Bikdeli, R Visvanathan, D Jimenez, M Monreal, SZ Goldhaber, B Bikdeli
Thrombosis and Haemostasis 119 (10), 1686-1694, 2019
Mandates: US National Institutes of Health
Prevention of venous thromboembolism in hospitalized medically ill patients: a US perspective
AC Spyropoulos, W Ageno, AT Cohen, CM Gibson, SZ Goldhaber, ...
Thrombosis and Haemostasis 120 (06), 924-936, 2020
Mandates: US National Institutes of Health
When Direct Oral Anticoagulants Should Not Be Standard Treatment: JACC State-of-the-Art Review
A Bejjani, CD Khairani, A Assi, G Piazza, P Sadeghipour, AH Talasaz, ...
Journal of the American College of Cardiology 83 (3), 444-465, 2024
Mandates: European Commission
Profile of patients diagnosed with acute venous thromboembolism in routine clinical practice: the RE-COVERY DVT/PE™ study
SZ Goldhaber, W Ageno, IB Casella, KH Chee, S Schellong, DE Singer, ...
The American Journal of Medicine 133 (8), 936-945, 2020
Mandates: US National Institutes of Health, American Heart Association
Trends in management and outcomes of pulmonary embolism with a multidisciplinary response team
R Chopard, U Campia, L Morin, KS Jering, ZI Almarzooq, JE Snyder, ...
Journal of Thrombosis and Thrombolysis 54 (3), 449-460, 2022
Mandates: US National Institutes of Health
Effect of dabigatran on referrals to and switching from warfarin in two academic anticoagulation management services
JK Atay, J Fanikos, GD Barnes, M Ehle, J Coatney, G Piazza, JB Froehlich, ...
The American journal of cardiology 112 (3), 387-389, 2013
Mandates: US National Institutes of Health
Meta-analysis comparing direct oral anticoagulants to low molecular weight heparin for treatment of venous thromboembolism in patients with cancer
K Bhatia, G Uberoi, NS Bajaj, V Jain, S Arora, A Tafur, S Bangalore, ...
American Journal of Cardiology 133, 175-178, 2020
Mandates: US National Institutes of Health
Safety and effectiveness of dabigatran in routine clinical practice: the RE-COVERY DVT/PE study
SZ Goldhaber, W Ageno, IB Casella, KH Chee, S Schellong, DE Singer, ...
Journal of Thrombosis and Thrombolysis 53 (2), 399-409, 2022
Mandates: US National Institutes of Health
Atrial fibrillation patients on warfarin and their transition to direct oral anticoagulants
P Collins, A Lewin, NV Irving, K Sylvester, J Fanikos, SZ Goldhaber, ...
Critical pathways in cardiology 20 (2), 103-107, 2021
Mandates: US National Institutes of Health
Scoring systems for diagnosis of acute venous thromboembolism
G Le Gal, M Righini, PS Wells
Seminars in thrombosis and hemostasis 43 (05), 479-485, 2017
Mandates: Heart and Stroke Foundation of Canada
Women's representation in venous thromboembolism randomized trials and registries: The illustrative example of direct oral anticoagulants for acute treatment
B Bikdeli, CD Khairani, BM Barns, RP Rosovsky, D Jimenez, M Monreal, ...
Contemporary clinical trials 115, 106714, 2022
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program